Fluticasone Propionate in Inflammatory Bowel Disease
Although effective for both acute and often long term treatment of inflammatory bowel disease, systemically absorbed corticosteroids have a high incidence of side effects. This article briefly reviews the pharmacokinetics of corticosteroids and the strategics available for reducing systemic side eff...
Saved in:
Main Authors: | Marta Carpani de Kaski, Humphery JF Hodgson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1990-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1990/769365 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD)
by: Hilla Mills, et al.
Published: (2022-01-01) -
Comparison of Once- with Twice-Daily Dosing of Fluticasone Propionate in Mild and Moderate Asthma
by: Louis-Philippe Boulet, et al.
Published: (2000-01-01) -
In vitro effects of fluticasone propionate
on IL-13 production by mitogen-stimulated lymphocytes
by: Gabriele Di Lorenzo, et al.
Published: (2002-01-01) -
Retracted: Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD)
by: Emergency Medicine International
Published: (2024-01-01) -
A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: a clinical evaluation
by: N. Ringdal, et al.
Published: (1996-01-01)